- Home
- Publications
- Publication Search
- Publication Details
Title
Update on the Pharmacological Treatment of Chronic Migraine
Authors
Keywords
Chronic migraine, Migraine treatment, OnabotulinumtoxinA, Topiramate, Emerging migraine treatments, Monoclonal antibodies to CGRP or its receptor
Journal
Current Pain and Headache Reports
Volume 20, Issue 1, Pages -
Publisher
Springer Nature
Online
2016-01-04
DOI
10.1007/s11916-015-0533-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Targeting CGRP: A New Era for Migraine Treatment
- (2015) Stephanie Wrobel Goldberg et al. CNS DRUGS
- AVP-825 Breath-Powered Intranasal Delivery System Containing 22 mg Sumatriptan Powder vs 100 mg Oral Sumatriptan in the Acute Treatment of Migraines (The COMPASS Study): A Comparative Randomized Clinical Trial Across Multiple Attacks
- (2015) Stewart J. Tepper et al. HEADACHE
- Safety, tolerability, and efficacy of TEV-48125 for preventive treatment of chronic migraine: a multicentre, randomised, double-blind, placebo-controlled, phase 2b study
- (2015) Marcelo E Bigal et al. LANCET NEUROLOGY
- Safety, tolerability, and efficacy of TEV-48125 for preventive treatment of high-frequency episodic migraine: a multicentre, randomised, double-blind, placebo-controlled, phase 2b study
- (2015) Marcelo E Bigal et al. LANCET NEUROLOGY
- Adherence to oral migraine-preventive medications among patients with chronic migraine
- (2014) Zsolt Hepp et al. CEPHALALGIA
- Pooled analysis of the safety and tolerability of onabotulinumtoxinA in the treatment of chronic migraine
- (2014) H.-C. Diener et al. EUROPEAN JOURNAL OF NEUROLOGY
- A Randomized, Double-Blind, Placebo-Controlled Study of Breath Powered Nasal Delivery of Sumatriptan Powder (AVP-825) in the Treatment of Acute Migraine (The TARGET Study)
- (2014) Roger K. Cady et al. HEADACHE
- Safety and efficacy of LY2951742, a monoclonal antibody to calcitonin gene-related peptide, for the prevention of migraine: a phase 2, randomised, double-blind, placebo-controlled study
- (2014) David W Dodick et al. LANCET NEUROLOGY
- Safety and efficacy of ALD403, an antibody to calcitonin gene-related peptide, for the prevention of frequent episodic migraine: a randomised, double-blind, placebo-controlled, exploratory phase 2 trial
- (2014) David W Dodick et al. LANCET NEUROLOGY
- Safety and tolerability of LBR-101, a humanized monoclonal antibody that blocks the binding of CGRP to its receptor: Results of the Phase 1 program
- (2013) Marcelo E Bigal et al. CEPHALALGIA
- The International Classification of Headache Disorders, 3rd edition (beta version)
- (2013) CEPHALALGIA
- Orally Inhaled Dihydroergotamine: A Review
- (2013) Stewart J. Tepper HEADACHE
- OnabotulinumtoxinA for treatment of chronic migraine: PREEMPT 24-week pooled subgroup analysis of patients who had acute headache medication overuse at baseline
- (2013) Stephen D. Silberstein et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- A randomized controlled trial of intranasal ketamine in migraine with prolonged aura
- (2013) S. K. Afridi et al. NEUROLOGY
- Acid-sensing ion channel 1: A novel therapeutic target for migraine with aura
- (2012) Philip R. Holland et al. ANNALS OF NEUROLOGY
- A Sumatriptan Iontophoretic Transdermal System for the Acute Treatment of Migraine
- (2012) Jerome Goldstein et al. HEADACHE
- The Association of Obesity With Episodic and Chronic Migraine
- (2012) Randolph W. Evans et al. HEADACHE
- Chronic Migraine Prevalence, Disability, and Sociodemographic Factors: Results From the American Migraine Prevalence and Prevention Study
- (2012) Dawn C. Buse et al. HEADACHE
- Efficacy and tolerability of lasmiditan, an oral 5-HT1F receptor agonist, for the acute treatment of migraine: a phase 2 randomised, placebo-controlled, parallel-group, dose-ranging study
- (2012) Markus Färkkilä et al. LANCET NEUROLOGY
- Bariatric surgery in obese migraineurs: Mounting evidence but important questions remain
- (2011) B Lee Peterlin CEPHALALGIA
- Detoxification for medication overuse headache is not necessary
- (2011) Hans-Christoph Diener CEPHALALGIA
- Detoxification for medication overuse headache is the primary task
- (2011) Jes Olesen CEPHALALGIA
- The International Burden of Migraine Study (IBMS): Study design, methodology, and baseline cohort characteristics
- (2011) Krista A Payne et al. CEPHALALGIA
- Alternative Headache Treatments: Nutraceuticals, Behavioral and Physical Treatments
- (2011) Christina Sun-Edelstein et al. HEADACHE
- MAP0004, Orally Inhaled DHE: A Randomized, Controlled Study in the Acute Treatment of Migraine
- (2011) Sheena K. Aurora et al. HEADACHE
- Preclinical pharmacological profile of the selective 5-HT1F receptor agonist lasmiditan
- (2010) David L Nelson et al. CEPHALALGIA
- Intranasal sumatriptan powder delivered by a novel breath-actuated bi-directional device for the acute treatment of migraine: A randomised, placebo-controlled study
- (2010) PG Djupesland et al. CEPHALALGIA
- BI 44370 TA, an oral CGRP antagonist for the treatment of acute migraine attacks: Results from a phase II study
- (2010) Hans-Christoph Diener et al. CEPHALALGIA
- OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial
- (2010) SK Aurora et al. CEPHALALGIA
- Disability, HRQoL and resource use among chronic and episodic migraineurs: Results from the International Burden of Migraine Study (IBMS)
- (2010) AM Blumenfeld et al. CEPHALALGIA
- OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial
- (2010) HC Diener et al. CEPHALALGIA
- Pregabalin in the Treatment of Chronic Migraine
- (2010) Elena P. Calandre et al. CLINICAL NEUROPHARMACOLOGY
- Sleep and Headache
- (2010) Jeanetta C. Rains et al. Current Treatment Options in Neurology
- Amitriptyline in the Prophylactic Treatment of Migraine and Chronic Daily Headache
- (2010) James R. Couch et al. HEADACHE
- Method of Injection of OnabotulinumtoxinA for Chronic Migraine: A Safe, Well-Tolerated, and Effective Treatment Paradigm Based on the PREEMPT Clinical Program
- (2010) Andrew Blumenfeld et al. HEADACHE
- OnabotulinumtoxinA for Treatment of Chronic Migraine: Pooled Results From the Double-Blind, Randomized, Placebo-Controlled Phases of the PREEMPT Clinical Program
- (2010) David W. Dodick et al. HEADACHE
- Utility of Topiramate for the Treatment of Patients with Chronic Migraine in the Presence or Absence of Acute Medication Overuse
- (2009) H-C Diener et al. CEPHALALGIA
- Global prevalence of chronic migraine: A systematic review
- (2009) JL Natoli et al. CEPHALALGIA
- Topiramate Treatment of Chronic Migraine: A Randomized, Placebo-Controlled Trial of Quality of Life and Other Efficacy Measures
- (2009) Stephen Silberstein et al. HEADACHE
- Psychiatric comorbidity in patients with chronic daily headache and migraine: a selective overview including personality traits and suicide risk
- (2009) Maurizio Pompili et al. JOURNAL OF HEADACHE AND PAIN
- Zonisamide for Migraine Prophylaxis in Patients Refractory to Topiramate
- (2008) Pedro Emilio Bermejo et al. CLINICAL NEUROPHARMACOLOGY
- Memantine in the Preventive Treatment of Refractory Migraine
- (2008) Marcelo Bigal et al. HEADACHE
- Acute Migraine Medications and Evolution From Episodic to Chronic Migraine: A Longitudinal Population-Based Study
- (2008) Marcelo E. Bigal et al. HEADACHE
- The effect of sodium valproate on chronic daily headache and its subgroups
- (2008) Vedat Ali Yurekli et al. JOURNAL OF HEADACHE AND PAIN
- Chronic migraine in the population: Burden, diagnosis, and satisfaction with treatment
- (2008) M. E. Bigal et al. NEUROLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now